Skip to main navigation
About Us
Overview
Executive Management Team
History
Distributor Partners
Contact Us
Products
Overview
Orthobiologics
ORTHOVISC
ORTHOVISC MINI
MONOVISC
CINGAL
ORTHOVISC-T
HYALOFAST
HYALONECT
HYALOGLIDE
Dermal
HYALOMATRIX
HYALOFILL
HYALOGRAN
HYALOSAFE
ELEVESS
Surgical
HYALOBARRIER
INCERT-S
ENT
– EPIDISC
– EPIDISC TM
– EPIFILM
– MEROGEL
– MEROGEL INJECTABLE
Other HA Solutions
ANIKAVISC
HYALOSS MATRIX
HYVISC
Technology
Overview
HA Biology
HA by Design
Pipeline
Clinical Trials
Investor Relations
Corporate Overview
Corporate Governance
Executive Management Team
Board of Directors
Committee Composition Chart
Stock Information
Historic Stock Lookup
Investment Calculator
Ownership Profile
Analyst Coverage
SEC Filings
Annual Reports and Proxies
Quarterly Results
News Releases
Events & Presentations
Investor FAQs
Careers
Overview
Life at Anika
Benefits & Perks
Explore Jobs
Search
Investor Relations
Q2 2017 Anika Therapeutics Earnings Conference Call
Jul 27, 2017 9:00 AM EDT
Listen to webcast
